Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.
复制标题
DOI:
10.1016/j.ccr.2014.03.014
复制
发表时间:
2014-05-12
期刊:
影响因子:
50.3
通讯作者:
Leach SD
中科院分区:
文献类型:
--
作者:
McAllister F;Bailey JM;Alsina J;Nirschl CJ;Sharma R;Fan H;Rattigan Y;Roeser JC;Lankapalli RH;Zhang H;Jaffee EM;Drake CG;Housseau F;Maitra A;Kolls JK;Sears CL;Pardoll DM;Leach SD
Many human cancers are dramatically accelerated by chronic inflammation. However the specific cellular and molecular elements mediating this effect remain largely unknown. Using a murine model of pancreatic intraepithelial neoplasia (PanIN), we found that KrasG12D induces expression of functional IL-17 receptors on PanIN epithelial cells, and also stimulates infiltration of the pancreatic stroma by IL-17-producing immune cells. Both effects are augmented by associated chronic pancreatitis, resulting in functional in vivo changes in PanIN epithelial gene expression. Forced IL-17 overexpression dramatically accelerates PanIN initiation and progression, while inhibition of IL-17 signaling using genetic or pharmacologic techniques effectively prevents PanIN formation. Together, these studies suggest that a hematopoietic-to-epithelial IL-17 signaling axis is a potent and requisite driver of PanIN formation.